▶ 調査レポート

ドライパウダー吸入器の世界市場2020年:メーカー別、地域別、種類・用途別

• 英文タイトル:Global Dry Powder Inhaler Device Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。ドライパウダー吸入器の世界市場2020年:メーカー別、地域別、種類・用途別 / Global Dry Powder Inhaler Device Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 / MRC2012A3042資料のイメージです。• レポートコード:MRC2012A3042
• 出版社/出版日:GlobalInfoResearch / 2020年12月21日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、104ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:医療、製薬
• 販売価格(消費税別)
  Single User¥522,000 (USD3,480)▷ お問い合わせ
  Multi User¥783,000 (USD5,220)▷ お問い合わせ
  Corporate User¥1,044,000 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、ドライパウダー吸入器の世界市場を広く調査・分析し、今後の市場展望をまとめております。ドライパウダー吸入器の種類別市場規模(単回投与、複数回投与)、用途別市場規模(喘息、COPD、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(販売量、市場シェア、製品概要、SWOT分析):GlaxoSmithKline、Mannkind、Chiesi、AstraZeneca、Hovione、Boehringer Ingelheim、Novartis、3M、Cipla、Mylan、Schering/Merck、Teva、Vectura、
・地域別グローバル市場分析 2015年-2020年
・ドライパウダー吸入器の北米市場(アメリカ、カナダ、メキシコ)
・ドライパウダー吸入器のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・ドライパウダー吸入器のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・ドライパウダー吸入器の南米市場(ブラジル、アルゼンチン)
・ドライパウダー吸入器の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:単回投与、複数回投与
・用途別分析:喘息、COPD、その他
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論

Market Overview
The Dry Powder Inhaler Device market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global Dry Powder Inhaler Device market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.7%% in the forecast period of 2020 to 2025 and will expected to reach USD 880.2 million by 2025, from USD 732.8 million in 2019.

Market segmentation
Dry Powder Inhaler Device market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Dry Powder Inhaler Device market has been segmented into
Single Dose
Multi-dose

By Application, Dry Powder Inhaler Device has been segmented into:
Asthma
COPD
Other

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Dry Powder Inhaler Device market presented in the report. This section sheds light on the sales growth of different regional and country-level Dry Powder Inhaler Device markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Dry Powder Inhaler Device market.

The report offers in-depth assessment of the growth and other aspects of the Dry Powder Inhaler Device market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Dry Powder Inhaler Device Market Share Analysis
Dry Powder Inhaler Device competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Dry Powder Inhaler Device sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Dry Powder Inhaler Device sales, revenue and market share for each player covered in this report.

The major players covered in Dry Powder Inhaler Device are:
GlaxoSmithKline
Mannkind
Chiesi
AstraZeneca
Hovione
Boehringer Ingelheim
Novartis
3M
Cipla
Mylan
Schering/Merck
Teva
Vectura

Among other players domestic and global, Dry Powder Inhaler Device market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Dry Powder Inhaler Device product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Dry Powder Inhaler Device, with price, sales, revenue and global market share of Dry Powder Inhaler Device in 2018 and 2019.
Chapter 3, the Dry Powder Inhaler Device competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Dry Powder Inhaler Device breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Dry Powder Inhaler Device market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Dry Powder Inhaler Device sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

1 Market Overview
1.1 Dry Powder Inhaler Device Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Dry Powder Inhaler Device Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Single Dose
1.2.3 Multi-dose
1.3 Market Analysis by Application
1.3.1 Overview: Global Dry Powder Inhaler Device Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Asthma
1.3.3 COPD
1.3.4 Other
1.4 Overview of Global Dry Powder Inhaler Device Market
1.4.1 Global Dry Powder Inhaler Device Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 GlaxoSmithKline
2.1.1 GlaxoSmithKline Details
2.1.2 GlaxoSmithKline Major Business
2.1.3 GlaxoSmithKline SWOT Analysis
2.1.4 GlaxoSmithKline Product and Services
2.1.5 GlaxoSmithKline Dry Powder Inhaler Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Mannkind
2.2.1 Mannkind Details
2.2.2 Mannkind Major Business
2.2.3 Mannkind SWOT Analysis
2.2.4 Mannkind Product and Services
2.2.5 Mannkind Dry Powder Inhaler Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Chiesi
2.3.1 Chiesi Details
2.3.2 Chiesi Major Business
2.3.3 Chiesi SWOT Analysis
2.3.4 Chiesi Product and Services
2.3.5 Chiesi Dry Powder Inhaler Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 AstraZeneca
2.4.1 AstraZeneca Details
2.4.2 AstraZeneca Major Business
2.4.3 AstraZeneca SWOT Analysis
2.4.4 AstraZeneca Product and Services
2.4.5 AstraZeneca Dry Powder Inhaler Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Hovione
2.5.1 Hovione Details
2.5.2 Hovione Major Business
2.5.3 Hovione SWOT Analysis
2.5.4 Hovione Product and Services
2.5.5 Hovione Dry Powder Inhaler Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Boehringer Ingelheim
2.6.1 Boehringer Ingelheim Details
2.6.2 Boehringer Ingelheim Major Business
2.6.3 Boehringer Ingelheim Product and Services
2.6.4 Boehringer Ingelheim Dry Powder Inhaler Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Novartis
2.7.1 Novartis Details
2.7.2 Novartis Major Business
2.7.3 Novartis Product and Services
2.7.4 Novartis Dry Powder Inhaler Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 3M
2.8.1 3M Details
2.8.2 3M Major Business
2.8.3 3M Product and Services
2.8.4 3M Dry Powder Inhaler Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Cipla
2.9.1 Cipla Details
2.9.2 Cipla Major Business
2.9.3 Cipla Product and Services
2.9.4 Cipla Dry Powder Inhaler Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Mylan
2.10.1 Mylan Details
2.10.2 Mylan Major Business
2.10.3 Mylan Product and Services
2.10.4 Mylan Dry Powder Inhaler Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Schering/Merck
2.11.1 Schering/Merck Details
2.11.2 Schering/Merck Major Business
2.11.3 Schering/Merck Product and Services
2.11.4 Schering/Merck Dry Powder Inhaler Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Teva
2.12.1 Teva Details
2.12.2 Teva Major Business
2.12.3 Teva Product and Services
2.12.4 Teva Dry Powder Inhaler Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Vectura
2.13.1 Vectura Details
2.13.2 Vectura Major Business
2.13.3 Vectura Product and Services
2.13.4 Vectura Dry Powder Inhaler Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Dry Powder Inhaler Device Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Dry Powder Inhaler Device Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Dry Powder Inhaler Device Manufacturer Market Share in 2019
3.3.2 Top 6 Dry Powder Inhaler Device Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Dry Powder Inhaler Device Sales, Revenue and Market Share by Regions
4.1.1 Global Dry Powder Inhaler Device Sales and Market Share by Regions (2015-2020)
4.1.2 Global Dry Powder Inhaler Device Revenue and Market Share by Regions (2015-2020)
4.2 North America Dry Powder Inhaler Device Sales and Growth Rate (2015-2020)
4.3 Europe Dry Powder Inhaler Device Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Dry Powder Inhaler Device Sales and Growth Rate (2015-2020)
4.5 South America Dry Powder Inhaler Device Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Dry Powder Inhaler Device Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Dry Powder Inhaler Device Sales, Revenue and Market Share by Country
5.1.1 North America Dry Powder Inhaler Device Sales and Market Share by Country (2015-2020)
5.1.2 North America Dry Powder Inhaler Device Revenue and Market Share by Country (2015-2020)
5.2 United States Dry Powder Inhaler Device Sales and Growth Rate (2015-2020)
5.3 Canada Dry Powder Inhaler Device Sales and Growth Rate (2015-2020)
5.4 Mexico Dry Powder Inhaler Device Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Dry Powder Inhaler Device Sales, Revenue and Market Share by Country
6.1.1 Europe Dry Powder Inhaler Device Sales and Market Share by Country (2015-2020)
6.1.2 Europe Dry Powder Inhaler Device Revenue and Market Share by Country (2015-2020)
6.2 Germany Dry Powder Inhaler Device Sales and Growth Rate (2015-2020)
6.3 UK Dry Powder Inhaler Device Sales and Growth Rate (2015-2020)
6.4 France Dry Powder Inhaler Device Sales and Growth Rate (2015-2020)
6.5 Russia Dry Powder Inhaler Device Sales and Growth Rate (2015-2020)
6.6 Italy Dry Powder Inhaler Device Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Dry Powder Inhaler Device Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Dry Powder Inhaler Device Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Dry Powder Inhaler Device Revenue and Market Share by Regions (2015-2020)
7.2 China Dry Powder Inhaler Device Sales and Growth Rate (2015-2020)
7.3 Japan Dry Powder Inhaler Device Sales and Growth Rate (2015-2020)
7.4 Korea Dry Powder Inhaler Device Sales and Growth Rate (2015-2020)
7.5 India Dry Powder Inhaler Device Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Dry Powder Inhaler Device Sales and Growth Rate (2015-2020)
7.7 Australia Dry Powder Inhaler Device Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Dry Powder Inhaler Device Sales, Revenue and Market Share by Country
8.1.1 South America Dry Powder Inhaler Device Sales and Market Share by Country (2015-2020)
8.1.2 South America Dry Powder Inhaler Device Revenue and Market Share by Country (2015-2020)
8.2 Brazil Dry Powder Inhaler Device Sales and Growth Rate (2015-2020)
8.3 Argentina Dry Powder Inhaler Device Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Dry Powder Inhaler Device Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Dry Powder Inhaler Device Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Dry Powder Inhaler Device Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Dry Powder Inhaler Device Sales and Growth Rate (2015-2020)
9.3 Turkey Dry Powder Inhaler Device Sales and Growth Rate (2015-2020)
9.4 Egypt Dry Powder Inhaler Device Sales and Growth Rate (2015-2020)
9.5 South Africa Dry Powder Inhaler Device Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Dry Powder Inhaler Device Sales and Market Share by Type (2015-2020)
10.2 Global Dry Powder Inhaler Device Revenue and Market Share by Type (2015-2020)
10.3 Global Dry Powder Inhaler Device Price by Type (2015-2020)
11 Global Dry Powder Inhaler Device Market Segment by Application
11.1 Global Dry Powder Inhaler Device Sales Market Share by Application (2015-2020)
11.2 Global Dry Powder Inhaler Device Revenue Market Share by Application (2015-2020)
11.3 Global Dry Powder Inhaler Device Price by Application (2015-2020)
12 Market Forecast
12.1 Global Dry Powder Inhaler Device Sales, Revenue and Growth Rate (2021-2025)
12.2 Dry Powder Inhaler Device Market Forecast by Regions (2021-2025)
12.2.1 North America Dry Powder Inhaler Device Market Forecast (2021-2025)
12.2.2 Europe Dry Powder Inhaler Device Market Forecast (2021-2025)
12.2.3 Asia-Pacific Dry Powder Inhaler Device Market Forecast (2021-2025)
12.2.4 South America Dry Powder Inhaler Device Market Forecast (2021-2025)
12.2.5 Middle East & Africa Dry Powder Inhaler Device Market Forecast (2021-2025)
12.3 Dry Powder Inhaler Device Market Forecast by Type (2021-2025)
12.3.1 Global Dry Powder Inhaler Device Sales Forecast by Type (2021-2025)
12.3.2 Global Dry Powder Inhaler Device Market Share Forecast by Type (2021-2025)
12.4 Dry Powder Inhaler Device Market Forecast by Application (2021-2025)
12.4.1 Global Dry Powder Inhaler Device Sales Forecast by Application (2021-2025)
12.4.2 Global Dry Powder Inhaler Device Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables
Table 1. Global Dry Powder Inhaler Device Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Dry Powder Inhaler Device by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Dry Powder Inhaler Device Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Dry Powder Inhaler Device Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 9. GlaxoSmithKline Dry Powder Inhaler Device Major Business
Table 10. GlaxoSmithKline Dry Powder Inhaler Device Total Revenue (USD Million) (2018-2019)
Table 11. GlaxoSmithKline SWOT Analysis
Table 12. GlaxoSmithKline Dry Powder Inhaler Device Product and Services
Table 13. GlaxoSmithKline Dry Powder Inhaler Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Mannkind Basic Information, Manufacturing Base and Competitors
Table 15. Mannkind Dry Powder Inhaler Device Major Business
Table 16. Mannkind Dry Powder Inhaler Device Total Revenue (USD Million) (2018-2019)
Table 17. Mannkind SWOT Analysis
Table 18. Mannkind Dry Powder Inhaler Device Product and Services
Table 19. Mannkind Dry Powder Inhaler Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Chiesi Basic Information, Manufacturing Base and Competitors
Table 21. Chiesi Dry Powder Inhaler Device Major Business
Table 22. Chiesi Dry Powder Inhaler Device Total Revenue (USD Million) (2018-2019)
Table 23. Chiesi SWOT Analysis
Table 24. Chiesi Dry Powder Inhaler Device Product and Services
Table 25. Chiesi Dry Powder Inhaler Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 27. AstraZeneca Dry Powder Inhaler Device Major Business
Table 28. AstraZeneca Dry Powder Inhaler Device Total Revenue (USD Million) (2018-2019)
Table 29. AstraZeneca SWOT Analysis
Table 30. AstraZeneca Dry Powder Inhaler Device Product and Services
Table 31. AstraZeneca Dry Powder Inhaler Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Hovione Basic Information, Manufacturing Base and Competitors
Table 33. Hovione Dry Powder Inhaler Device Major Business
Table 34. Hovione Dry Powder Inhaler Device Total Revenue (USD Million) (2018-2019)
Table 35. Hovione SWOT Analysis
Table 36. Hovione Dry Powder Inhaler Device Product and Services
Table 37. Hovione Dry Powder Inhaler Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 39. Boehringer Ingelheim Dry Powder Inhaler Device Major Business
Table 40. Boehringer Ingelheim Dry Powder Inhaler Device Total Revenue (USD Million) (2018-2019)
Table 41. Boehringer Ingelheim SWOT Analysis
Table 42. Boehringer Ingelheim Dry Powder Inhaler Device Product and Services
Table 43. Boehringer Ingelheim Dry Powder Inhaler Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Novartis Basic Information, Manufacturing Base and Competitors
Table 45. Novartis Dry Powder Inhaler Device Major Business
Table 46. Novartis Dry Powder Inhaler Device Total Revenue (USD Million) (2018-2019)
Table 47. Novartis SWOT Analysis
Table 48. Novartis Dry Powder Inhaler Device Product and Services
Table 49. Novartis Dry Powder Inhaler Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. 3M Basic Information, Manufacturing Base and Competitors
Table 51. 3M Dry Powder Inhaler Device Major Business
Table 52. 3M Dry Powder Inhaler Device Total Revenue (USD Million) (2018-2019)
Table 53. 3M SWOT Analysis
Table 54. 3M Dry Powder Inhaler Device Product and Services
Table 55. 3M Dry Powder Inhaler Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. Cipla Basic Information, Manufacturing Base and Competitors
Table 57. Cipla Dry Powder Inhaler Device Major Business
Table 58. Cipla Dry Powder Inhaler Device Total Revenue (USD Million) (2018-2019)
Table 59. Cipla SWOT Analysis
Table 60. Cipla Dry Powder Inhaler Device Product and Services
Table 61. Cipla Dry Powder Inhaler Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 62. Mylan Basic Information, Manufacturing Base and Competitors
Table 63. Mylan Dry Powder Inhaler Device Major Business
Table 64. Mylan Dry Powder Inhaler Device Total Revenue (USD Million) (2018-2019)
Table 65. Mylan SWOT Analysis
Table 66. Mylan Dry Powder Inhaler Device Product and Services
Table 67. Mylan Dry Powder Inhaler Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 68. Schering/Merck Basic Information, Manufacturing Base and Competitors
Table 69. Schering/Merck Dry Powder Inhaler Device Major Business
Table 70. Schering/Merck Dry Powder Inhaler Device Total Revenue (USD Million) (2018-2019)
Table 71. Schering/Merck SWOT Analysis
Table 72. Schering/Merck Dry Powder Inhaler Device Product and Services
Table 73. Schering/Merck Dry Powder Inhaler Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 74. Teva Basic Information, Manufacturing Base and Competitors
Table 75. Teva Dry Powder Inhaler Device Major Business
Table 76. Teva Dry Powder Inhaler Device Total Revenue (USD Million) (2018-2019)
Table 77. Teva SWOT Analysis
Table 78. Teva Dry Powder Inhaler Device Product and Services
Table 79. Teva Dry Powder Inhaler Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 80. Vectura Basic Information, Manufacturing Base and Competitors
Table 81. Vectura Dry Powder Inhaler Device Major Business
Table 82. Vectura Dry Powder Inhaler Device Total Revenue (USD Million) (2018-2019)
Table 83. Vectura SWOT Analysis
Table 84. Vectura Dry Powder Inhaler Device Product and Services
Table 85. Vectura Dry Powder Inhaler Device Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 86. Global Dry Powder Inhaler Device Sales by Manufacturer (2018-2019) (K Units)
Table 87. Global Dry Powder Inhaler Device Revenue by Manufacturer (2018-2019) (USD Million)
Table 88. Global Dry Powder Inhaler Device Sales by Regions (2015-2020) (K Units)
Table 89. Global Dry Powder Inhaler Device Sales Market Share by Regions (2015-2020)
Table 90. Global Dry Powder Inhaler Device Revenue by Regions (2015-2020) (USD Million)
Table 91. North America Dry Powder Inhaler Device Sales by Countries (2015-2020) (K Units)
Table 92. North America Dry Powder Inhaler Device Sales Market Share by Countries (2015-2020)
Table 93. North America Dry Powder Inhaler Device Revenue by Countries (2015-2020) (USD Million)
Table 94. North America Dry Powder Inhaler Device Revenue Market Share by Countries (2015-2020)
Table 95. Europe Dry Powder Inhaler Device Sales by Countries (2015-2020) (K Units)
Table 96. Europe Dry Powder Inhaler Device Sales Market Share by Countries (2015-2020)
Table 97. Europe Dry Powder Inhaler Device Revenue by Countries (2015-2020) (USD Million)
Table 98. Asia-Pacific Dry Powder Inhaler Device Sales by Regions (2015-2020) (K Units)
Table 99. Asia-Pacific Dry Powder Inhaler Device Sales Market Share by Regions (2015-2020)
Table 100. Asia-Pacific Dry Powder Inhaler Device Revenue by Regions (2015-2020) (USD Million)
Table 101. South America Dry Powder Inhaler Device Sales by Countries (2015-2020) (K Units)
Table 102. South America Dry Powder Inhaler Device Sales Market Share by Countries (2015-2020)
Table 103. South America Dry Powder Inhaler Device Revenue by Countries (2015-2020) (USD Million)
Table 104. South America Dry Powder Inhaler Device Revenue Market Share by Countries (2015-2020)
Table 105. Middle East & Africa Dry Powder Inhaler Device Sales by Countries (2015-2020) (K Units)
Table 106. Middle East & Africa Dry Powder Inhaler Device Sales Market Share by Countries (2015-2020)
Table 107. Middle East & Africa Dry Powder Inhaler Device Revenue by Countries (2015-2020) (USD Million)
Table 108. Middle East & Africa Dry Powder Inhaler Device Revenue Market Share by Countries (2015-2020)
Table 109. Global Dry Powder Inhaler Device Sales by Type (2015-2020) (K Units)
Table 110. Global Dry Powder Inhaler Device Sales Share by Type (2015-2020)
Table 111. Global Dry Powder Inhaler Device Revenue by Type (2015-2020) (USD Million)
Table 112. Global Dry Powder Inhaler Device Revenue Share by Type (2015-2020)
Table 113. Global Dry Powder Inhaler Device Sales by Application (2015-2020) (K Units)
Table 114. Global Dry Powder Inhaler Device Sales Share by Application (2015-2020)
Table 115. Global Dry Powder Inhaler Device Sales Forecast by Regions (2021-2025) (K Units)
Table 116. Global Dry Powder Inhaler Device Market Share Forecast by Regions (2021-2025)
Table 117. Global Dry Powder Inhaler Device Sales Forecast by Type (2021-2025) (K Units)
Table 118. Global Dry Powder Inhaler Device Market Share Forecast by Type (2021-2025)
Table 119. Global Dry Powder Inhaler Device Sales Forecast by Application (2021-2025)
Table 120. Global Dry Powder Inhaler Device Market Share Forecast by Application (2021-2025)
Table 121. Direct Channel Pros & Cons
Table 122. Indirect Channel Pros & Cons
Table 123. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Dry Powder Inhaler Device Picture
Figure 2. Global Sales Market Share of Dry Powder Inhaler Device by Type in 2019
Figure 3. Single Dose Picture
Figure 4. Multi-dose Picture
Figure 5. Dry Powder Inhaler Device Sales Market Share by Application in 2019
Figure 6. Asthma Picture
Figure 7. COPD Picture
Figure 8. Other Picture
Figure 9. Global Dry Powder Inhaler Device Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Dry Powder Inhaler Device Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Dry Powder Inhaler Device Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Dry Powder Inhaler Device Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Dry Powder Inhaler Device Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Dry Powder Inhaler Device Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Dry Powder Inhaler Device Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Dry Powder Inhaler Device Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Dry Powder Inhaler Device Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Dry Powder Inhaler Device Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Dry Powder Inhaler Device Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Dry Powder Inhaler Device Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Dry Powder Inhaler Device Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Dry Powder Inhaler Device Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Dry Powder Inhaler Device Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Dry Powder Inhaler Device Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Dry Powder Inhaler Device Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Dry Powder Inhaler Device Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Dry Powder Inhaler Device Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Dry Powder Inhaler Device Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Dry Powder Inhaler Device Sales Market Share by Manufacturer in 2019
Figure 30. Global Dry Powder Inhaler Device Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Dry Powder Inhaler Device Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Dry Powder Inhaler Device Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Dry Powder Inhaler Device Sales and Growth Rate (2015-2020) (K Units)
Figure 35. Global Dry Powder Inhaler Device Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Dry Powder Inhaler Device Revenue Market Share by Regions (2015-2020)
Figure 37. Global Dry Powder Inhaler Device Revenue Market Share by Regions in 2018
Figure 38. North America Dry Powder Inhaler Device Sales and Growth Rate (2015-2020)
Figure 39. Europe Dry Powder Inhaler Device Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Dry Powder Inhaler Device Sales and Growth Rate (2015-2020)
Figure 41. South America Dry Powder Inhaler Device Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Dry Powder Inhaler Device Sales and Growth Rate (2015-2020)
Figure 43. North America Dry Powder Inhaler Device Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Dry Powder Inhaler Device Sales Market Share by Countries (2015-2020)
Figure 45. North America Dry Powder Inhaler Device Sales Market Share by Countries in 2018
Figure 46. North America Dry Powder Inhaler Device Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Dry Powder Inhaler Device Revenue Market Share by Countries in 2018
Figure 48. United States Dry Powder Inhaler Device Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Canada Dry Powder Inhaler Device Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Mexico Dry Powder Inhaler Device Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Europe Dry Powder Inhaler Device Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Dry Powder Inhaler Device Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Dry Powder Inhaler Device Revenue Market Share by Countries in 2019
Figure 54. Germany Dry Powder Inhaler Device Sales and Growth Rate (2015-2020) (K Units)
Figure 55. UK Dry Powder Inhaler Device Sales and Growth Rate (2015-2020) (K Units)
Figure 56. France Dry Powder Inhaler Device Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Russia Dry Powder Inhaler Device Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Italy Dry Powder Inhaler Device Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Asia-Pacific Dry Powder Inhaler Device Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Dry Powder Inhaler Device Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Dry Powder Inhaler Device Revenue Market Share by Regions 2019
Figure 62. China Dry Powder Inhaler Device Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Japan Dry Powder Inhaler Device Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Korea Dry Powder Inhaler Device Sales and Growth Rate (2015-2020) (K Units)
Figure 65. India Dry Powder Inhaler Device Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Southeast Asia Dry Powder Inhaler Device Sales and Growth Rate (2015-2020) (K Units)
Figure 67. South America Dry Powder Inhaler Device Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Dry Powder Inhaler Device Sales Market Share by Countries in 2019
Figure 69. South America Dry Powder Inhaler Device Revenue Market Share by Countries in 2019
Figure 70. Brazil Dry Powder Inhaler Device Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Argentina Dry Powder Inhaler Device Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Middle East and Africa Dry Powder Inhaler Device Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Dry Powder Inhaler Device Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Dry Powder Inhaler Device Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Dry Powder Inhaler Device Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Dry Powder Inhaler Device Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Egypt Dry Powder Inhaler Device Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Turkey Dry Powder Inhaler Device Sales and Growth Rate (2015-2020) (K Units)
Figure 79. South Africa Dry Powder Inhaler Device Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Global Dry Powder Inhaler Device Sales and Growth Rate (2021-2025) (K Units)
Figure 81. Global Dry Powder Inhaler Device Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Dry Powder Inhaler Device Market Forecast (2021-2025) (K Units)
Figure 83. Europe Sales Dry Powder Inhaler Device Market Forecast (2021-2025) (K Units)
Figure 84. Asia-Pacific Sales Dry Powder Inhaler Device Market Forecast (2021-2025) (K Units)
Figure 85. South America Sales Dry Powder Inhaler Device Market Forecast (2021-2025) (K Units)
Figure 86. Middle East & Africa Sales Dry Powder Inhaler Device Market Forecast (2021-2025) (K Units)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel